We are live on
!
Find out more
CCA
Checchi Capital Advisers Portfolio holdings
AUM
$1.46B
1-Year Est. Return
19.17%
This Fund
S&P 500
This Quarter
Est. Return
-0.27%
1 Year Est. Return
+19.17%
3 Year Est. Return
+56.07%
5 Year Est. Return
+61.01%
10 Year Est. Return
+221.06%
AUM
$308M
AUM Growth
+$13.5M
(+4.6%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
5.17%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
381
New
29
Increased
205
Reduced
121
Closed
18
Top Buys
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$2.11M |
| 2 |
iShares MSCI India ETF
INDA
|
+$1.9M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$1.45M |
| 4 |
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
|
+$1.43M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$1.24M |
Top Sells
| 1 |
Vanguard Mega Cap Growth ETF
MGK
|
+$574K |
| 2 |
iShares MBS ETF
MBB
|
+$390K |
| 3 |
Vanguard Growth ETF
VUG
|
+$374K |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$372K |
| 5 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$353K |
Sector Composition
| 1 | Healthcare | 10.02% |
| 2 | Technology | 9.29% |
| 3 | Financials | 8.43% |
| 4 | Consumer Staples | 5.59% |
| 5 | Communication Services | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$163B
| $1.55M | 0.5% |
13,202
-884
| -6% | -$96.6K |
|
52
Novartis
NVS
$293B
| $1.52M | 0.5% |
17,294
+1,974
| +13% | +$181K |
|
53
Philip Morris
PM
$281B
| $1.52M | 0.49% |
18,905
-440
| -2% | -$36.2K |
|
54
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $1.4M | 0.46% |
29,208
-2,104
| -7% | -$106K |
|
55
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.93B
| $1.34M | 0.43% |
15,672
+677
| +5% | +$60.6K |
|
56
Bank of America
BAC
$422B
| $1.34M | 0.43% |
78,508
+2,386
| +3% | +$39.3K |
|
57
Deere & Co
DE
$158B
| $1.33M | 0.43% |
13,682
+95
| +0.7% | +$8.64K |
|
|
58
Ionis Pharmaceuticals
IONS
$9.38B
| $1.32M | 0.43% |
+22,859
| New | +$1.45M |
|
59
Toyota
TM
$207B
| $1.26M | 0.41% |
9,437
+1,145
| +14% | +$158K |
|
60
Citigroup
C
$240B
| $1.22M | 0.4% |
22,076
+2,132
| +11% | +$116K |
|
61
TJX Companies
TJX
$166B
| $1.18M | 0.38% |
35,700
-240
| -0.7% | -$7.98K |
|
62
PepsiCo
PEP
$189B
| $1.07M | 0.35% |
11,501
-2,447
| -18% | -$234K |
|
63
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.06M | 0.34% |
7,761
+519
| +7% | +$74K |
|
64
GSK
GSK
$105B
| $1.05M | 0.34% |
20,160
+1,066
| +6% | +$60K |
|
65
Altria Group
MO
$120B
| $1.04M | 0.34% |
21,274
-1,137
| -5% | -$57.6K |
|
66
Amazon
AMZN
$2.66T
| $1.04M | 0.34% |
47,880
-4,800
| -9% | -$100K |
|
67
Comcast
CMCSA
$85.6B
| $1M | 0.33% |
33,394
-2,528
| -7% | -$74.2K |
|
68
Bristol-Myers Squibb
BMY
$121B
| $992K | 0.32% |
14,914
-588
| -4% | -$38.8K |
|
69
Alkermes
ALKS
$8.65B
| $972K | 0.32% |
+15,114
| New | +$925K |
|
70
CVS Health
CVS
$135B
| $958K | 0.31% |
9,137
-1,075
| -11% | -$110K |
|
71
Amgen
AMGN
$195B
| $950K | 0.31% |
6,187
-636
| -9% | -$102K |
|
72
AbbVie
ABBV
$438B
| $932K | 0.3% |
13,871
-52
| -0.4% | -$3.4K |
|
73
Meta Platforms (Facebook)
META
$1.67T
| $926K | 0.3% |
10,802
-424
| -4% | -$34.6K |
|
|
RDS.A
74
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $921K | 0.3% |
16,150
+1,194
| +8% | +$72.7K |
|
75
RTX Corp
RTX
$264B
| $920K | 0.3% |
13,181
+696
| +6% | +$51.1K |
|
Similar funds
L7C
SAW
BFA
SWA
VCP
AC
CIAS
KFGK